330
Views
23
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Dual Diagnosis and Suicide Risk in a Spanish Outpatient Sample

, , , , , , , & show all
Pages 383-389 | Published online: 04 Jan 2012

REFERENCES

  • Appleby, L., Shaw, J., Amos, T., McDonnell, R., Harris, C., McCann, K., (1999). Suicide within 12 months of contact with mental health services: National clinical survey. British Medical Journal, 318(7193), 1235–1239.
  • Baldacchino, A. (2007). Co-morbid substance misuse and mental health problems: Policy and practice in Scotland. American Journal on Addictions, 16(3), 147–159.
  • Calvo Pinero, N., Caseras Vives, X., Gutierrez Ponce De Leon, F., & Torrubia Beltri, R. (2002). Spanish version of the personality diagnostic questionnaire-4+ (PDQ-4+). Actas Españolas de Psiquiatría, 30(1), 7–13.
  • Compton, W. M., Thomas, Y. F., Conway, K. P., & Colliver, J. D. (2005). Developments in the epidemiology of drug use and drug use disorders. American Journal of Psychiatry, 162(8), 1494–1502.
  • Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from thenational epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566–576.
  • Cornelius, J. R., Salloum, I. M., Mezzich, J., Cornelius, M. D., Fabrega, H., Jr., Ehler, J. G., (1995). Disproportionate suicidality in patients with comorbid major depression and alcoholism. American Journal of Psychiatry, 152(3), 358–364.
  • Frisher, M., Crome, I., Macleod, J., Millson, D., & Croft, P. (2005). Substance misuse and psychiatric illness: Prospective observational study using the general practice research database. Journal of Epidemiology and Community Health, 59(10), 847–850.
  • Glantz, M. D., Anthony, J. C., Berglund, P. A., Degenhardt, L., Dierker, L., Kalaydjian, A., (2009). Mental disorders as risk factors for later substance dependence: Estimates of optimal prevention and treatment benefits. Psychological Medicine, 39(8), 1365–1377.
  • Grant, B. F. (1995). Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey of adults. Journal of Substance Abuse, 7(4), 481–497.
  • Grella, C. E., & Hser, Y. I. (1997). A county survey of mental health services in drug treatment programs. Psychiatric Services, 48(7), 950–952.
  • Gual, A. (2007). Dual diagnosis in Spain. Drug and Alcohol Review, 26(1), 65–71.
  • Hides, L., Samet, S., & Lubman, D. I. (2010). Cognitive behaviour therapy (CBT) for the treatment of co-occurring depression and substance use: Current evidence and directions for future research. Drug and Alcohol Review, 29(5), 508–517.
  • Hunt, I. M., Kapur, N., Robinson, J., Shaw, J., Flynn, S., Bailey, H., (2006). Suicide within 12 months of mental healthservice contact in different age and diagnostic groups: National clinical survey. British Journal of Psychiatry, 188, 135–142.
  • Kessler, R. C. (2004). The epidemiology of dual diagnosis. Biological Psychiatry, 56(10), 730–737.
  • Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51(1), 8–19.
  • Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66(1), 17–31.
  • Lukasiewicz, M., Blecha, L., Falissard, B., Neveu, X., Benyamina, A., Reynaud, M., (2009). Dual diagnosis: Prevalence, risk factors, and relationship with suicide risk in a nationwide sample of French prisoners. Alcoholism, Clinical and Experimental Research, 33, 160–168.
  • Merikangas, K. R., Mehta, R. L., Molnar, B. E., Walters, E. E., Swendsen, J. D., Aguilar-Gaziola, S., (1998). Comorbidity of substance use disorders with mood and anxiety disorders: Results of the International Consortium in Psychiatric Epidemiology. Addictive Behaviors, 23(6), 893–907.
  • Ouimette, P., Jemelka, R., Hall, J., Brimner, K., Krupski, A., & Stark, K. (2007). Services to patients with dual diagnoses: Findings from Washington's mental health service system. Substance Use & Misuse, 42(1), 113–127.
  • Pawsey, B., & Castle, D. (2006). Substance use and psychosis. Australian Family Physician, 35(3), 110–112.
  • Regier, D. A., Farmer, M. E., & Rae, D. S. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Result from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association, 264, 2511–2518.
  • Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22–33.
  • Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183, 304–313.
  • World Health Organization. (1992). International classification of diseases (ICD). Retrieved August 23, 2011, from http://www.who.int/classifications/icd/en/.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.